Blood test shows promise for detecting testicular cancer when standard markers miss
April 28, 2026
April 28, 2026
ROCHESTER, Minnesota, April 28 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Blood test shows promise for detecting testicular cancer when standard markers miss
*
ROCHESTER, Minn. - Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study publ . . .
* * *
Blood test shows promise for detecting testicular cancer when standard markers miss
*
ROCHESTER, Minn. - Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study publ . . .